ProfileGDS4718 / 221853_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 96% 94% 93% 95% 94% 96% 95% 94% 93% 95% 95% 93% 95% 96% 95% 96% 94% 95% 95% 85% 96% 95% 95% 94% 95% 94% 94% 95% 93% 94% 96% 95% 93% 95% 96% 96% 94% 94% 94% 92% 92% 94% 96% 96% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.535796
GSM549102patient 115, normal, homogenized [OPG study]10.057694
GSM549104patient 119, normal, homogenized [OPG study]9.7386593
GSM549108patient 138, normal, homogenized [OPG study]10.231795
GSM549119patient 077, normal, homogenized [OPG study]10.088394
GSM549133patient 032, cancer, homogenized [OPG study]10.57296
GSM549139patient 042, cancer, homogenized [OPG study]10.20495
GSM549099patient 107, normal, homogenized [OPG study]9.9569794
GSM549109patient 139, normal, homogenized [OPG study]9.7765793
GSM549110patient 046, normal, homogenized [OPG study]10.452995
GSM549114patient 063, normal, homogenized [OPG study]10.37495
GSM549122patient 082, normal, homogenized [OPG study]9.8559193
GSM549134patient 033, cancer, homogenized [OPG study]10.329995
GSM549136patient 036, cancer, homogenized [OPG study]10.521796
GSM549140patient 044, cancer, homogenized [OPG study]10.178395
GSM549111patient 047, normal, homogenized [OPG study]10.545296
GSM549113patient 057, normal, homogenized [OPG study]10.30794
GSM549132patient 031, cancer, homogenized [OPG study]10.285195
GSM549137patient 038, cancer, homogenized [OPG study]10.212995
GSM549142patient 047, cancer, homogenized [OPG study]8.1071485
GSM549100patient 110, normal, homogenized [OPG study]10.439696
GSM549107patient 135, normal, homogenized [OPG study]10.294995
GSM549115patient 068, normal, homogenized [OPG study]10.356295
GSM549116patient 072, normal, homogenized [OPG study]10.056794
GSM549120patient 078, normal, homogenized [OPG study]10.423795
GSM549131patient 030, cancer, homogenized [OPG study]10.000394
GSM549118patient 074, normal, homogenized [OPG study]9.9482994
GSM549129patient 027, cancer, homogenized [OPG study]10.097795
GSM549123patient 088, normal, homogenized [OPG study]9.9396493
GSM549124patient 006, cancer, homogenized [OPG study]9.7128894
GSM549126patient 015, cancer, homogenized [OPG study]10.565496
GSM549128patient 025, cancer, homogenized [OPG study]10.198295
GSM549103patient 117, normal, homogenized [OPG study]9.6797893
GSM549117patient 073, normal, homogenized [OPG study]10.374395
GSM549138patient 041, cancer, homogenized [OPG study]10.515396
GSM549141patient 045, cancer, homogenized [OPG study]10.644796
GSM549130patient 028, cancer, homogenized [OPG study]9.8088794
GSM549101patient 111, normal, homogenized [OPG study]9.826794
GSM549105patient 128, normal, homogenized [OPG study]9.9477294
GSM549106patient 134, normal, homogenized [OPG study]9.6179392
GSM549112patient 048, normal, homogenized [OPG study]9.7368792
GSM549125patient 011, cancer, homogenized [OPG study]9.8956994
GSM549127patient 024, cancer, homogenized [OPG study]10.408696
GSM549135patient 035, cancer, homogenized [OPG study]10.387796